US Pharma Faces First Drug Pricing Fight Of 2021
Executive Summary
A $16bn provision to increase rebates in the US Medicaid program is a surprise inclusion in the COVID relief package moving through Congress. It looks like an uphill fight for industry to stop it from happening.